Method and kit for the field diagnosis of caprine arthritis-encephalitis virus (CAEV) infection
US-10161012-B2 · Dec 25, 2018 · US
US9885091B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9885091-B2 |
| Application number | US-201314420720-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 13, 2013 |
| Priority date | Aug 14, 2012 |
| Publication date | Feb 6, 2018 |
| Grant date | Feb 6, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A forward primer of a primer set in accordance with the present invention for detecting BLV is a mixture of (1) a first primer consisting of a polynucleotide including 15 or more successive bases including the 16th C in the base sequence of SEQ ID NO: 1 and (2) a second primer consisting of a plurality of kinds of polynucleotides including at least the first to 15th bases in the base sequence of SEQ ID NO: 2. Two or more of M, N, Y, K, and D which are included in the second primer are each a degenerate base which specifies two or more kinds of bases, and the second primer includes at least 10 kinds of polynucleotides including at least the first to 15th bases in the base sequences of SEQ ID NOs: 3 to 12.
Opening claim text (preview).
The invention claimed is: 1. A primer set capable of amplifying, through polymerase chain reaction, a DNA fragment derived from bovine leukemia virus, consisting of a combination of a forward primer and a reverse primer, wherein the forward primer is a mixture of (1) a first primer consisting of a polynucleotide including 15 or more successive bases including the 16th cytosine in the base sequence of SEQ ID NO: 1 and (2) a second primer consisting of a plurality of polynucleotides including at least the first to 15th bases in the base sequence of SEQ ID NO: 2, in the SEQ ID NO: 2, a base M representing A or C, a base N representing A, C, G, or T, a base Y representing C or T, a base K representing G or T, a base D representing A, G, or T, two or more bases among the base M, the base N, the base Y, the base K, and the base D which are included in the second primer each being a degenerate base which specifies two or more bases, the plurality of polynucleotides of the second primer including at least polynucleotides including at least the first to 15th bases in the base sequences of SEQ ID NOs: 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12, wherein the reverse primer is a primer that is capable of hybridizing with the DNA fragment derived from bovine leukemia virus and amplifying the DNA fragment having a predetermined size through PCR. 2. The primer set according to claim 1 , wherein each of the base M, the base N, the base Y, the base K, and the base D included in the second primer is a degenerate base which specifies all the possible bases. 3. The primer set according to claim 1 , wherein the plurality of second primer consists of a plurality of different polynucleotides, each of said polynucleotides including at least the first to 18th bases in the base sequence of SEQ ID NO: 2. 4. A kit for detecting bovine leukemia virus, comprising a primer set according to claim 1 . 5. A method for detecting bovine leukemia virus, comprising the steps of: (a) preparing, from a subject sample, an analyte containing DNA; (b) performing polymerase chain reaction on the analyte with use of a primer set according to claim 1 ; and (c) detecting an amplified fragment obtained by the step (b). 6. The primer set according to claim 1 , wherein the reverse primer is polynucleotide which includes at least 7th to 14th bases in the base sequence of SEQ ID NO: 14 and has a length of not less than 15 base length but less than 50 base length, wherein the degenerate base S represents G or C.
Expression markers · CPC title
for retroviruses · CPC title
Antineoplastic agents · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.